RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Acella Pharmaceuticals, LLC 2025-10-15 Health serious FDA
Health · FDA · Recall #FDA-D-0014-2026

Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by:… Recall

Issued October 15, 2025 · Acella Pharmaceuticals, LLC

In October 2025, Acella Pharmaceuticals, LLC recalled the Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by:…, a serious health recall reported by the FDA.

Compiled by Maya Ellison, RecallCheckr

What this means for you

Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

What you should do

  1. 1 Stop using Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by:… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Acella Pharmaceuticals, LLC to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Acella Pharmaceuticals, LLC
Category
Health
Recall date
October 15, 2025
Units affected
Not reported
Sold at
Nationwide in the USA
Recall number
FDA-D-0014-2026
Made in
United States
Issuing agency
FDA

In context

  • Acella Pharmaceuticals, LLC has 4 recalls in our database.
  • We're tracking 3,576 Health recalls in our database.
  • This is the 691st Health recall we've logged in 2025.
Read the official FDA notice

Related recalls